Operaciones BIOLASE - BIOL CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.14 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.024068% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.001846% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Estadísticas clave
| Cierre previo* | 4.54 |
| Abrir* | 4.38 |
| Cambio de 1 año* | 1.62% |
| Rango del día* | 4.26 - 4.58 |
| Rango de 52 semanas | 0.30-9.24 |
| Volumen medio (10 días) | 279.87K |
| Volumen medio (3 meses) | 11.92M |
| Capitalización de mercado | 12.99M |
| Ratio P/E | -100.00K |
| Acciones en circulación | 35.58M |
| Ingresos | 46.82M |
| EPS | -3.68 |
| Dividendo (Rendimiento %) | N/A |
| Beta | 1.43 |
| Próxima fecha de resultados | Mar 28, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| Jun 29, 2022 | 4.30 | -0.08 | -1.83% | 4.38 | 4.58 | 4.22 |
| Jun 28, 2022 | 4.54 | 0.32 | 7.58% | 4.22 | 5.00 | 4.22 |
| Jun 27, 2022 | 5.08 | 0.86 | 20.38% | 4.22 | 5.19 | 4.22 |
| Jun 24, 2022 | 4.47 | 0.25 | 5.92% | 4.22 | 4.60 | 4.22 |
| Jun 23, 2022 | 4.19 | 0.12 | 2.95% | 4.07 | 4.30 | 4.07 |
| Jun 22, 2022 | 4.05 | -0.27 | -6.25% | 4.32 | 4.52 | 3.99 |
| Jun 21, 2022 | 4.32 | 0.04 | 0.93% | 4.28 | 4.53 | 4.16 |
| Jun 17, 2022 | 4.51 | 0.22 | 5.13% | 4.29 | 4.51 | 4.29 |
| Jun 16, 2022 | 4.17 | -0.01 | -0.24% | 4.18 | 4.37 | 4.16 |
| Jun 15, 2022 | 4.26 | 0.19 | 4.67% | 4.07 | 4.26 | 4.07 |
| Jun 14, 2022 | 4.26 | 0.17 | 4.16% | 4.09 | 4.37 | 4.09 |
| Jun 13, 2022 | 4.10 | -0.17 | -3.98% | 4.27 | 4.34 | 4.07 |
| Jun 10, 2022 | 4.56 | -0.06 | -1.30% | 4.62 | 4.62 | 4.47 |
| Jun 9, 2022 | 4.67 | 0.03 | 0.65% | 4.64 | 4.76 | 4.64 |
| Jun 8, 2022 | 4.63 | 0.01 | 0.22% | 4.62 | 4.71 | 4.59 |
| Jun 7, 2022 | 4.64 | 0.02 | 0.43% | 4.62 | 4.73 | 4.62 |
| Jun 6, 2022 | 4.67 | 0.03 | 0.65% | 4.64 | 4.79 | 4.59 |
| Jun 3, 2022 | 4.82 | 0.20 | 4.33% | 4.62 | 4.90 | 4.62 |
| Jun 2, 2022 | 4.67 | 0.04 | 0.86% | 4.63 | 4.80 | 4.61 |
| Jun 1, 2022 | 4.63 | -0.15 | -3.14% | 4.78 | 4.78 | 4.57 |
BIOLASE Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| No events scheduled | ||
- Anual
- Trimestral
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Ingresos totales | 39.188 | 22.78 | 37.799 | 46.155 | 46.926 |
| Ingresos | 39.188 | 22.78 | 37.799 | 46.155 | 46.926 |
| Coste de los ingresos, total | 22.659 | 16.607 | 23.511 | 29.26 | 31.8 |
| Beneficio bruto | 16.529 | 6.173 | 14.288 | 16.895 | 15.126 |
| Gastos totales de explotación | 52.605 | 41.316 | 53.42 | 67.04 | 64.964 |
| Gastos de venta/general/administración Gastos, total | 26.597 | 21.014 | 25.144 | 29.892 | 26.43 |
| Investigación y desarrollo | 6.048 | 3.695 | 4.765 | 5.203 | 6.229 |
| Gastos (ingresos) extraordinarios | -2.699 | 0 | 0 | 2.685 | 0.505 |
| Ingresos de explotación | -13.417 | -18.536 | -15.621 | -20.885 | -18.038 |
| Ingresos por intereses (gastos), netos No operativos | -2.676 | -2.38 | -2.278 | -0.568 | 0.605 |
| Ingresos netos antes de impuestos | -16.093 | -16.701 | -17.899 | -21.453 | -17.433 |
| Ingresos netos después de impuestos | -16.158 | -16.829 | -17.855 | -22.116 | 4.249 |
| Beneficio neto antes de partidas extra. Elementos | -16.158 | -16.829 | -17.855 | -22.116 | 4.249 |
| Ingresos netos | -16.158 | -16.829 | -17.855 | -21.516 | -16.851 |
| Total Adjustments to Net Income | -0.546 | -17.378 | 0 | 0 | -3.978 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -16.704 | -34.207 | -17.855 | -22.116 | 0.271 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -16.704 | -34.207 | -17.855 | -21.516 | -20.829 |
| Beneficio neto diluido | -16.704 | -34.207 | -17.855 | -21.516 | -20.829 |
| Promedio ponderado de acciones diluidas | 5.90984 | 2.44544 | 0.92804 | 0.82352 | 0.59007 |
| BPA diluido sin partidas extraordinarias | -2.82647 | -13.9881 | -19.2395 | -26.8554 | 0.45927 |
| BPA normalizado diluido | -3.12332 | -13.9881 | -19.2395 | -24.7362 | 1.01555 |
| Total de partidas extraordinarias | 0.6 | -21.1 | |||
| Otros, netos | 0 | 4.215 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Ingresos totales | 10.166 | 12.408 | 9.531 | 9.134 | 8.116 |
| Ingresos | 10.166 | 12.408 | 9.531 | 9.134 | 8.116 |
| Coste de los ingresos, total | 5.437 | 7.502 | 4.689 | 5.093 | 5.375 |
| Beneficio bruto | 4.729 | 4.906 | 4.842 | 4.041 | 2.741 |
| Gastos totales de explotación | 14.372 | 16.838 | 12.188 | 9.403 | 14.178 |
| Gastos de venta/general/administración Gastos, total | 7.391 | 7.669 | 5.93 | 6.09 | 7 |
| Investigación y desarrollo | 1.544 | 1.542 | 1.54 | 1.162 | 1.803 |
| Ingresos de explotación | -4.206 | -4.43 | -2.657 | -0.269 | -6.062 |
| Ingresos por intereses (gastos), netos No operativos | -0.553 | -0.777 | -0.605 | -0.513 | -0.779 |
| Ingresos netos antes de impuestos | -4.759 | -5.207 | -3.262 | -0.782 | -6.841 |
| Ingresos netos después de impuestos | -4.776 | -5.279 | -3.276 | -0.702 | -6.901 |
| Beneficio neto antes de partidas extra. Elementos | -4.776 | -5.279 | -3.276 | -0.702 | -6.901 |
| Ingresos netos | -4.776 | -5.279 | -3.276 | -0.702 | -6.901 |
| Total Adjustments to Net Income | -0.217 | 0 | -0.009 | -0.006 | -0.532 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -4.993 | -5.279 | -3.285 | -0.708 | -7.433 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -4.993 | -5.279 | -3.285 | -0.708 | -7.433 |
| Beneficio neto diluido | -4.993 | -5.279 | -3.285 | -0.708 | -7.433 |
| Promedio ponderado de acciones diluidas | 6.159 | 6.14228 | 6.07764 | 6.0266 | 5.38344 |
| BPA diluido sin partidas extraordinarias | -0.81068 | -0.85945 | -0.54051 | -0.11748 | -1.38072 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| BPA normalizado diluido | -0.81068 | -0.84622 | -0.5374 | -0.43479 | -1.38072 |
| Gastos (ingresos) extraordinarios | 0.125 | 0.029 | -2.942 | ||
| Otros, netos | 0 | 0 |
- Anual
- Trimestral
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 49.354 | 35.11 | 27.019 | 33.307 | 36.05 |
| Efectivo e inversiones a corto plazo | 29.972 | 17.564 | 5.789 | 8.044 | 11.645 |
| Efectivo y Equivalentes | 29.972 | 17.564 | 5.789 | 8.044 | 11.645 |
| Total deudores, neto | 4.238 | 3.059 | 8.76 | 11.112 | 10.124 |
| Accounts Receivable - Trade, Net | 4.238 | 3.059 | 8.76 | 10.99 | 10.047 |
| Total Inventory | 12.929 | 11.157 | 10.995 | 12.248 | 12.298 |
| Prepaid Expenses | 2.012 | 3.018 | 1.163 | 1.591 | 1.732 |
| Other Current Assets, Total | 0.203 | 0.312 | 0.312 | 0.312 | 0.251 |
| Total Assets | 55.284 | 41.025 | 31.847 | 38.516 | 42.984 |
| Property/Plant/Equipment, Total - Net | 2.784 | 2.758 | 1.469 | 1.975 | 3.674 |
| Property/Plant/Equipment, Total - Gross | 10.833 | 10.422 | 10.791 | 10.319 | 11.1 |
| Accumulated Depreciation, Total | -8.049 | -7.664 | -9.322 | -8.344 | -7.426 |
| Goodwill, Net | 2.926 | 2.926 | 2.926 | 2.926 | 2.926 |
| Intangibles, Net | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets, Total | 0.22 | 0.231 | 0.433 | 0.308 | 0.334 |
| Total Current Liabilities | 13.844 | 11.223 | 25.779 | 15.967 | 13.37 |
| Accounts Payable | 3.309 | 2.651 | 5.332 | 5.953 | 5.109 |
| Accrued Expenses | 6.619 | 5.771 | 3.79 | 6.133 | 4.689 |
| Notes Payable/Short Term Debt | 0 | 0 | 13.466 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | ||||
| Other Current Liabilities, Total | 3.916 | 2.801 | 3.191 | 3.881 | 3.572 |
| Total Liabilities | 30.076 | 30.997 | 27.505 | 27.427 | 13.724 |
| Total Long Term Debt | 13.603 | 16.186 | 0 | 10.836 | 0 |
| Capital Lease Obligations | |||||
| Deferred Income Tax | 0.078 | 0.077 | 0.104 | ||
| Other Liabilities, Total | 2.629 | 3.588 | 1.648 | 0.547 | 0.25 |
| Total Equity | 25.208 | 10.028 | 4.342 | 11.089 | 29.26 |
| Common Stock | 0.154 | 0.098 | 0.031 | 0.021 | 0.102 |
| Additional Paid-In Capital | 293.177 | 261.573 | 235.594 | 228.43 | 224.91 |
| Retained Earnings (Accumulated Deficit) | -267.534 | -251.376 | -234.547 | -216.692 | -195.176 |
| Other Equity, Total | -0.623 | -0.385 | -0.701 | -0.67 | -0.576 |
| Total Liabilities & Shareholders’ Equity | 55.284 | 41.025 | 31.847 | 38.516 | 42.984 |
| Total Common Shares Outstanding | 6.14704 | 3.90654 | 1.25756 | 0.8429 | 0.81872 |
| Long Term Debt | 13.603 | 16.186 | 0 | 10.836 | |
| Redeemable Preferred Stock | 3.965 | ||||
| Total Preferred Shares Outstanding | 0 | 0 | 0.07 | ||
| Preferred Stock - Non Redeemable, Net | 0.034 | 0.118 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 43.783 | 49.354 | 52.654 | 55.34 | 57.749 |
| Efectivo e inversiones a corto plazo | 21.606 | 29.972 | 33.385 | 37.081 | 40.842 |
| Efectivo y Equivalentes | 21.606 | 29.972 | 33.385 | 37.081 | 40.842 |
| Total deudores, neto | 5.18 | 4.238 | 3.637 | 3.819 | 3.266 |
| Accounts Receivable - Trade, Net | 5.18 | 4.238 | 3.637 | 3.819 | 3.266 |
| Total Inventory | 14.611 | 12.929 | 14.062 | 12.715 | 11.877 |
| Prepaid Expenses | 2.183 | 2.012 | 1.366 | 1.521 | 1.56 |
| Other Current Assets, Total | 0.203 | 0.203 | 0.204 | 0.204 | 0.204 |
| Total Assets | 50.242 | 55.284 | 58.514 | 61.249 | 63.484 |
| Property/Plant/Equipment, Total - Net | 3.302 | 2.784 | 2.712 | 2.758 | 2.583 |
| Property/Plant/Equipment, Total - Gross | 11.469 | 10.833 | 10.643 | 10.587 | 10.324 |
| Accumulated Depreciation, Total | -8.167 | -8.049 | -7.931 | -7.829 | -7.741 |
| Goodwill, Net | 2.926 | 2.926 | 2.926 | 2.926 | 2.926 |
| Other Long Term Assets, Total | 0.231 | 0.22 | 0.222 | 0.225 | 0.226 |
| Total Current Liabilities | 13.112 | 13.844 | 13.457 | 12.719 | 11.27 |
| Accounts Payable | 4.643 | 3.309 | 3.597 | 3.502 | 3.072 |
| Accrued Expenses | 5.167 | 6.619 | 4.929 | 5.174 | 5.386 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0.7 | 0 |
| Other Current Liabilities, Total | 3.302 | 3.916 | 3.531 | 3.343 | 2.812 |
| Total Liabilities | 29.642 | 30.076 | 28.192 | 27.993 | 29.968 |
| Total Long Term Debt | 13.666 | 13.603 | 12.114 | 12.703 | 16.295 |
| Long Term Debt | 13.666 | 13.603 | 12.114 | 12.703 | 16.295 |
| Other Liabilities, Total | 2.864 | 2.629 | 2.621 | 2.571 | 2.403 |
| Total Equity | 20.6 | 25.208 | 30.322 | 33.256 | 33.516 |
| Preferred Stock - Non Redeemable, Net | 0 | 0.034 | 0.034 | 0.035 | 0.036 |
| Common Stock | 0.155 | 0.154 | 0.153 | 0.151 | 0.149 |
| Additional Paid-In Capital | 293.419 | 293.177 | 292.948 | 292.517 | 292.141 |
| Retained Earnings (Accumulated Deficit) | -272.31 | -267.534 | -262.255 | -258.979 | -258.277 |
| Other Equity, Total | -0.664 | -0.623 | -0.558 | -0.468 | -0.533 |
| Total Liabilities & Shareholders’ Equity | 50.242 | 55.284 | 58.514 | 61.249 | 63.484 |
| Total Common Shares Outstanding | 6.176 | 6.14704 | 6.13108 | 6.04944 | 5.97652 |
| Total Preferred Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 1.4 |
- Anual
- Trimestral
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | -16.158 | -16.829 | -17.855 | -21.516 | -16.851 |
| Efectivo de actividades de explotación | -16.71 | -12.795 | -12.746 | -14.147 | -18.412 |
| Efectivo de actividades de explotación | 0.4 | 0.499 | 0.982 | 0.945 | 1.203 |
| Deferred Taxes | 0.007 | -0.027 | -0.694 | ||
| Partidas no monetarias | 0.985 | 1.781 | 5.228 | 6.46 | 3.333 |
| Cash Taxes Paid | 0.171 | 0.022 | 0.035 | 0.044 | 0.164 |
| Intereses pagados en efectivo | 1.771 | 1.881 | 1.784 | 0.023 | 0.001 |
| Cambios en el capital circulante | -1.937 | 1.754 | -1.108 | -0.009 | -5.403 |
| Efectivo de actividades de inversión | -0.707 | -0.096 | -0.207 | -0.522 | -0.747 |
| Gastos de capital | -0.707 | -0.096 | -0.207 | -0.558 | -0.747 |
| Otras partidas de flujo de caja de inversión, total | 0 | 0.036 | 0 | ||
| Efectivo procedente de actividades de financiación | 29.954 | 24.349 | 10.721 | 11.235 | 21.618 |
| Elementos de flujo de caja de financiación | -1.135 | -3.049 | -0.954 | -1.222 | 0 |
| Emisión (retiro) de acciones, neto | 31.114 | 24.958 | 9.175 | 0.003 | 21.764 |
| Emisión (amortización) de deuda, neta | -0.025 | 2.44 | 2.5 | 12.454 | -0.146 |
| Efectos del cambio de divisas | -0.238 | 0.317 | -0.023 | -0.106 | 0.262 |
| Variación neta de la tesorería | 12.299 | 11.775 | -2.255 | -3.54 | 2.721 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -4.776 | -16.158 | -10.879 | -7.603 | -6.901 |
| Cash From Operating Activities | -8.021 | -16.71 | -13.606 | -10.008 | -6.499 |
| Cash From Operating Activities | 0.117 | 0.4 | 0.281 | 0.176 | 0.085 |
| Deferred Taxes | 0 | ||||
| Non-Cash Items | 0.42 | 0.985 | -1.035 | -1.461 | 1.118 |
| Cash Taxes Paid | 0.026 | 0.171 | 0.154 | 0.13 | 0.01 |
| Cash Interest Paid | 0.377 | 1.771 | 1.328 | 0.886 | 0.448 |
| Changes in Working Capital | -3.782 | -1.937 | -1.973 | -1.12 | -0.801 |
| Cash From Investing Activities | -0.304 | -0.707 | -0.396 | -0.311 | -0.008 |
| Capital Expenditures | -0.304 | -0.707 | -0.396 | -0.311 | -0.008 |
| Cash From Financing Activities | 0 | 29.954 | 29.886 | 29.811 | 29.825 |
| Financing Cash Flow Items | 0 | -1.135 | -0.006 | -0.006 | -0.006 |
| Issuance (Retirement) of Stock, Net | 0 | 31.114 | 29.917 | 29.841 | 29.831 |
| Foreign Exchange Effects | -0.041 | -0.238 | -0.171 | -0.083 | -0.148 |
| Net Change in Cash | -8.366 | 12.299 | 15.713 | 19.409 | 23.17 |
| Issuance (Retirement) of Debt, Net | -0.025 | -0.025 | -0.024 |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group500K+
Traders
92K+
Clientes activos mensualmente
$53M+
Volumen mensual de inversión
$30M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
BIOLASE Company profile
Sobre BIOLASE Inc
BIOLASE, Inc. es un proveedor de sistemas láser avanzados para la industria dental. La empresa desarrolla, fabrica, comercializa y vende sistemas láser, que proporcionan ayuda a los profesionales de la odontología y a sus pacientes. Los sistemas de la empresa permiten a los dentistas, periodoncistas, endodoncistas, dentistas pediátricos, cirujanos orales y otros especialistas dentales realizar una serie de procedimientos dentales, incluyendo aplicaciones cosméticas, restaurativas y quirúrgicas complejas. Ofrece dos categorías de productos de sistemas láser: Sistemas Waterlase (para todo tipo de tejidos) y sistemas de diodos (para tejidos blandos). Su marca Waterlase utiliza una combinación patentada de agua y energía láser y actúa con fresas, bisturíes y otros instrumentos dentales tradicionales para cortar tejidos blandos y duros. Ofrece sus sistemas de láser de diodo para realizar procedimientos de tejidos blandos, terapia del dolor y cosméticos, incluido el blanqueamiento dental. Tiene aproximadamente 301 patentes emitidas y 38 pendientes en Estados Unidos e internacionales.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
27042 Towne Centre Drive
Suite 270
FOOTHILL RANCH
CALIFORNIA 92610
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com